TMO reports Thursday, Jan 28, 2027, before the open. After the last 4 reports the stock moved +1.0%, +8.7%, −9.2%, −2.6% the next day.
TMO is expected to report on Thursday, Jan 28, 2027, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Oct 21, 2026 | 6.40 | 6.68 | +1.0% | +0.8% |
| Jul 23, 2026 | 5.71 | 6.03 | +8.7% | +9.5% |
| Apr 23, 2026 | 5.24 | 5.44 | −9.2% | −9.3% |
| Jan 29, 2026 | 6.45 | 6.57 | −2.6% | −7.0% |
| Oct 22, 2025 | 5.50 | 5.79 | +1.7% | −0.1% |
| Jul 23, 2025 | 5.23 | 5.36 | +9.1% | +12.8% |
| Apr 23, 2025 | 5.10 | 5.15 | −0.7% | −1.7% |
| Jan 30, 2025 | 5.94 | 6.10 | +6.8% | +2.5% |
Average move the next trading day over the last 8 reports: ±5.0% (5 of 8 up).
TMO is in an uptrend, momentum soft. $700 is the level overhead; $657.11 the first support below.
TMO at $698.34. Nearest resistance $700.00 (+0.2%). Nearest support $657.11 (−5.9%).
TMO chart, levels and analysis · Latest analysis: Thermo Fisher Scientific (TMO) stock analysis, November 3, 2026: Uptrend intact as shares press against $700 resistance · Earnings this week
TMO is expected to report on Thursday, Jan 28, 2027, before the open.
TMO reports before the open, US Eastern time.
After its report on Oct 21, 2026, TMO moved +1.0% the next trading day.
Over the last 8 reports, TMO moved 5.0% on average the next trading day, up 5 times out of 8.